Tien-Li Lee
CEO, Secretary & ChairmanDr. Tien-Li Lee, M.D., has been the Founder of Aardvark Therapeutics, Inc. and serves as its Chief Executive Officer since March 2017 and serves as its Secretary and Director and is its Chairman. He served as the Chief Strategy Officer of NantKwest, Inc. since June 2015 until February 21, 2017. He is a medical doctor and biotechnology business development expert who has been a co-founder or officer in several biotechnology companies, including Celladon Corporation, Amkor Pharma and Onkor Pharmaceuticals. He also serves as a consultant to Sorrento Therapeutics since January 2013. He served as a director of Scilex Holding Company from March 2019 to August 2023. He served as Vice President of Operations & Corporate Development at NantKwest, Inc. from March 2014 to June 2015. He served as the Director of Business Development for Simcere Pharmaceutical Group from March 2011 to December 2012. He served as Vice President of Business Development at Onkor Pharmaceuticals from January 2008 to March 2011. He was worked with Cellics Therapeutics. He has been a physician at a private medical clinic since 2009. He earned his M.D. degree from UC San Diego and received post-graduate training in Internal Medicine through UC Los Angeles and Physical Medicine and Rehabilitation at UC Irvine and his B.A. degree from UC Berkeley in Molecular Biology.
Positions
- Company NameAardvark Therapeutics, Inc.Stock CodeAARDPositionCEO, Secretary & ChairmanColleagues
- NBNelson B. SunCFO & COO
- MSManasi Sinha JaimanChief Medical Officer
- DSDvorit SamidExecutive Vice President of Medical Affairs
- ZZZhenhuan ZhengChief Research Officer
- CCChien-Chuen ChiLead Independent Director
- VEVictor E. TongIndependent Director
- SESusan E. GrafIndependent Director
- RDRoy D. BaynesIndependent Director
